FDA publishes updated PQ/CMC Document for Comments
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
In March, the U.S. FDA published the draft of the "Pharmaceutical Quality/Chemistry Manufacturing and Controls (PQ/CMC) Data Exchange" document for comments.
This document is part of a project, which has been in place since 2017 and includes the standardisation and structuring of submitted data from the PQ/CMC area in Module 3 of the electronic Common Technical Document (eCTD) . The following points are the central cornerstones of this project:
- The development of standards for the structured presentation of PQ/CMC data.
- The development of a standard exchange system to submit the structured PQ/CMC data to the U.S. FDA.
Already in 2017, the U.S. FDA had published the first draft of the document and convened a public meeting regarding the project in 2018. The summaries of this are also available on the U.S. FDA website.
Here you can find the draft version of the "Pharmaceutical Quality/Chemistry Manufacturing and Controls (PQ/CMC) Data Exchange" for the electronic submission of PQ/CMC data. The draft is available for comment until mid-May!
Related GMP News
02.11.2026Reprotoxic and Persistent: ECHA Committee Recommends New Classification for TFA
28.10.2026IPEC Publishes Version 3 of the Excipient Composition Guide
28.10.2026EMA and CMDh Expand List of Nitrosamine Limits
14.10.2026EMA Reports inconsistent Progress in International API Inspection Cooperation
23.09.2026FDA Warning Letter: serious GMP Deficiencies at a Chinese API Manufacturer
16.09.2026PFAS restriction: Commission highlights Importance of critical Medical Applications